期刊簡介預(yù)計審稿時間： 較慢,6-12周

Circulation: Heart Failure considers for publication content related to heart failure, mechanical circulatory support and heart transplant science and medicine, including studies conducted in humans or analyses of human data, as well as preclinical studies that have direct clinical correlation or relevance. As a primarily clinical journal, few basic and preclinical studies are ultimately published. Those that will be considered are novel, and significantly and directly advance the field of heart failure. The editors are especially interested in basic science studies directly related to heart failure that are highly informative and translatable to human disease and are conducted in vertebrate models. Less than 15% of submitted articles are ultimately published. Work not directly involving heart failure or heart failure therapies will not be considered, including work on mechanisms of myocardial infarction, reperfusion injury, or arrhythmia in the absence of heart failure substrate.

《循環(huán)：心力衰竭》雜志考慮發(fā)表與心力衰竭、機械循環(huán)支持和心臟移植科學(xué)和醫(yī)學(xué)相關(guān)的內(nèi)容，包括對人類進行的研究或?qū)θ祟悢?shù)據(jù)的分析，以及具有直接臨床相關(guān)性或相關(guān)性的臨床前研究。作為一本主要針對臨床的雜志，最終發(fā)表的基礎(chǔ)研究和臨床前研究很少。那些將被考慮的研究都是新穎的，并且對心力衰竭領(lǐng)域有重大而直接的推動作用。編輯們對與心力衰竭直接相關(guān)的基礎(chǔ)科學(xué)研究特別感興趣，這些研究信息量大，可轉(zhuǎn)化為人類疾病，并在脊椎動物模型中進行。提交的文章中，只有不到 15% 最終得以發(fā)表。不直接涉及心力衰竭或心力衰竭治療的研究將不予考慮，包括在沒有心力衰竭底物的情況下研究心肌梗死、再灌注損傷或心律失常的機制。

《Circulation-heart Failure》(循環(huán)心力衰竭)編輯部通訊方式為LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, USA, PA, 19106-3621。如果您需要協(xié)助投稿或潤稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對一投稿指導(dǎo)，避免您在投稿時頻繁碰壁，節(jié)省您的寶貴時間，有效提升發(fā)表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內(nèi)容。